(Q46966646)

English

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S

scientific article published in March 2006

Statements

Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: a prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer S (English)
Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit